|
US9931303B1
|
|
Abuse deterrent formulations of amphetamine
|
|
TW201605443A
|
|
Methods of treating fragile X syndrome and related disorders
|
|
US2015073023A1
|
|
Method Of Treating Fragile X Syndrome And Related Disorders
|
|
IL216896D0
|
|
Metadoxine and compositions comprising the same for use in the treatment of adhd/add in non-alcoholic subjects
|
|
IL210940D0
|
|
Substituted pyridoxine-lactam carboxylate salts
|
|
WO2011061743A1
|
|
Metadoxine and derivatives thereof for use in the treatment of inflammation and immune-related disorders
|
|
EP2445498A1
|
|
A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
|
|
WO2010013242A1
|
|
Substituted pyridoxine-lactam carboxylate salts
|
|
KR20160054632A
|
|
Pharmaceutical composition comprising metadoxine
|
